BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15363953)

  • 1. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.
    Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
    Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
    J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
    Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
    Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
    Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
    J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
    MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
    Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor.
    Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
    Br J Pharmacol; 1998 Sep; 125(2):365-72. PubMed ID: 9786510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors.
    Hess JF; Hey PJ; Chen TB; O'Brien J; Omalley SS; Pettibone DJ; Chang RS
    Biol Chem; 2001 Jan; 382(1):123-9. PubMed ID: 11258662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of bradykinin receptors in human lung fibroblasts using the binding of 3[H][Des-Arg10,Leu9]kallidin and [3H]NPC17731.
    Zhang SP; Codd EE
    Life Sci; 1998; 62(25):2303-14. PubMed ID: 9651119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
    Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
    J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation.
    Kuebler JF; Schremmer-Danninger E; Bhoola KD; Roscher AA; Messmer K; Hoffmann TF
    Biol Chem; 2003 Sep; 384(9):1311-9. PubMed ID: 14515994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization.
    Bastian S; Loillier B; Paquet JL; Pruneau D
    Br J Pharmacol; 1997 Sep; 122(2):393-9. PubMed ID: 9313952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
    Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production.
    Galizzi JP; Bodinier MC; Chapelain B; Ly SM; Coussy L; Giraud S; Neliat G; Jean T
    Br J Pharmacol; 1994 Oct; 113(2):389-94. PubMed ID: 7834189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
    Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
    Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor.
    Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1337-43. PubMed ID: 8667195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.